Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease

Abstract

These data indicate the intrarenal RAS may play an important role in the etiology of CKD, and urinary angiotensinogen may be a useful clinical biomarker for the identification of patients at a high risk for CKD.